Promoter holding
64.27%
RP
Rodec Pharma Limited - Due diligence report
A 360° intelligence report on Rodec Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress s…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Rodec Pharma Limited — 360° Intelligence Report
Generated from MCA filings & public records83/100
Trust Score
Low Risk
Rodec Pharma Limited is assessed as Low Risk with a Trust Score of 83/100. Rodec Pharma Limited is an active public limited indian non-government company incorporated in 1997, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 15 Oct 2026 from the latest processed filings. Rodec Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
61/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 5 open (142.48 cr) · 5 satisfied (8.51 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 4 | 48.0 cr |
| Axis Bank Limited | 4 | 48.0 cr |
| Punjab National Bank | 1 | 48.0 cr |
| Syndicate Bank | 1 | 48.0 cr |
Compliance Score: 61/100 Moderate
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
- Litigation present in 2 court forum(s).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| CHHAYA GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| UTKARSH GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MUKESH KUMAR GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Achal Kapoor | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Nikita Sinha | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Preeti | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Keshav Kumar Sharma | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Shivam Gupta | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 8 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 28+ years.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
5 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment82/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 5 open charge(s) of 142.48 cr already registered.
- Compliance gaps should be priced into terms.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events22 Nov 2025
Director appointed
Shivam Gupta (Cfo)
07 Sep 2025
Director appointed
Keshav Kumar Sharma (Company Secretary)
23 Aug 2025
Director appointed
Achal Kapoor (Additional Director)
Director appointed
Nikita Sinha (Additional Director)
Director appointed
Preeti (Additional Director)
30 Sep 2024
Last AGM held
Annual general meeting
22 Aug 2024
Charge created
Hdfc Bank Limited - 30.00 Lakh
14 Aug 2024
Charge satisfied
Axis Bank Limited
13 Aug 2024
Charge satisfied
Axis Bank Limited
31 Mar 2024
Latest balance sheet
Filed with ROC
29 Sep 2023
Director ceased
UTKARSH GUPTA
22 Jun 2023
Charge created
Hdfc Bank Limited - 16.60 Lakh
24 Mar 2023
Director appointed
UTKARSH GUPTA (Director)
Director ceased
SHUBHANGI GUPTA
29 Dec 2022
Charge created
Hdfc Bank Limited - 1.00 cr
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
8 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| JURIS EAGLE AND LEGAL SOLUTIONS LLP | AAO-5300 | East Delhi, Delhi |
| Sparkling Building Solutions Private Limited | U70102DL2012PTC231663 | Delhi |
| Dsc Leather Company Private Limited | U19116DL2012PTC235430 | Delhi |
| ALAG JEWELLERS PRIVATE LIMITED. | U51398DL1999PTC099545 | East Delhi, Delhi |
| Aethos Engitech Private Limited | U72900DL2021PTC389192 | Delhi |
| DREAMS INN HOTEL AND CONSULTING PRIVATE LIMITED | U55101DL2013PTC257387 | East Delhi, Delhi |
| Qcms Consultant Private Limited | U74999DL2022PTC404484 | Delhi |
| Exotica Infocom Private Limited | U72900DL2012PTC239118 | Delhi |
| Zapdor Healthcare Private Limited | U33100DL2020PTC364234 | Delhi |
| Ladda Infratech Private Limited | U45200DL2017PTC312828 | Delhi |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Rodec Pharma Limited before audits and certifications: compliance score 61/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Rodec Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Rodec Pharma Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Rodec Pharma Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Rodec Pharma Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Rodec Pharma Limited an active company?
Rodec Pharma Limited has MCA status “Active” with a compliance score of 61/100 (Moderate).
Is Rodec Pharma Limited financially healthy?
Rodec Pharma Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Rodec Pharma Limited?
Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Rodec Pharma Limited?
See the directors and ownership sections above for board and shareholding detail. 8 active director(s) are on record.
Does Rodec Pharma Limited have loans or charges against its assets?
5 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Rodec Pharma Limited up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 61/100 (Moderate).
Is it risky to lend to Rodec Pharma Limited?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
